Emami Paper Mills Limited
Emami Paper Mills Limited (EMAMIPAP.NS) Stock Competitors & Peer Comparison
See (EMAMIPAP.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial Materials Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMAMIPAP.NS | ₹86.70 | +0.09% | 5.2B | 18.05 | ₹4.78 | +1.85% |
| VEDL.NS | ₹737.60 | +6.11% | 2.8T | 20.20 | ₹36.03 | +3.16% |
| VEDL.BO | ₹735.30 | +5.74% | 2.8T | 20.20 | ₹36.03 | +3.16% |
| HINDZINC.NS | ₹609.20 | +1.98% | 2.6T | 22.16 | ₹27.94 | +4.68% |
| HINDZINC.BO | ₹609.30 | +1.83% | 2.6T | 22.15 | ₹27.93 | +4.68% |
| MOIL.NS | ₹308.15 | +3.23% | 62.6B | 21.54 | ₹14.28 | +2.26% |
| MOIL.BO | ₹308.20 | +3.28% | 62.6B | 21.53 | ₹14.28 | +2.26% |
| ASHAPURMIN.NS | ₹542.55 | +2.14% | 52.2B | 13.83 | ₹39.54 | +0.18% |
| ASHAPURMIN.BO | ₹542.95 | +2.24% | 52.2B | 13.83 | ₹39.51 | +0.18% |
| ORISSAMINE.NS | ₹4,209.40 | +1.39% | 25.2B | -94.16 | -₹44.52 | N/A |
Stock Comparison
EMAMIPAP.NS vs VEDL.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, VEDL.NS has a market cap of 2.8T. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while VEDL.NS trades at ₹737.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas VEDL.NS's P/E ratio is 20.20. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to VEDL.NS's ROE of +0.31%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to VEDL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check VEDL.NS's competition here
EMAMIPAP.NS vs VEDL.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, VEDL.BO has a market cap of 2.8T. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while VEDL.BO trades at ₹735.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas VEDL.BO's P/E ratio is 20.20. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to VEDL.BO's ROE of +0.31%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to VEDL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check VEDL.BO's competition here
EMAMIPAP.NS vs HINDZINC.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, HINDZINC.NS has a market cap of 2.6T. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while HINDZINC.NS trades at ₹609.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas HINDZINC.NS's P/E ratio is 22.16. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to HINDZINC.NS's ROE of +0.98%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to HINDZINC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check HINDZINC.NS's competition here
EMAMIPAP.NS vs HINDZINC.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, HINDZINC.BO has a market cap of 2.6T. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while HINDZINC.BO trades at ₹609.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas HINDZINC.BO's P/E ratio is 22.15. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to HINDZINC.BO's ROE of +0.98%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to HINDZINC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check HINDZINC.BO's competition here
EMAMIPAP.NS vs MOIL.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, MOIL.NS has a market cap of 62.6B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while MOIL.NS trades at ₹308.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas MOIL.NS's P/E ratio is 21.54. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to MOIL.NS's ROE of +0.11%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to MOIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check MOIL.NS's competition here
EMAMIPAP.NS vs MOIL.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, MOIL.BO has a market cap of 62.6B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while MOIL.BO trades at ₹308.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas MOIL.BO's P/E ratio is 21.53. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to MOIL.BO's ROE of +0.11%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to MOIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check MOIL.BO's competition here
EMAMIPAP.NS vs ASHAPURMIN.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, ASHAPURMIN.NS has a market cap of 52.2B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while ASHAPURMIN.NS trades at ₹542.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas ASHAPURMIN.NS's P/E ratio is 13.83. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to ASHAPURMIN.NS's ROE of +0.31%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to ASHAPURMIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check ASHAPURMIN.NS's competition here
EMAMIPAP.NS vs ASHAPURMIN.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, ASHAPURMIN.BO has a market cap of 52.2B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while ASHAPURMIN.BO trades at ₹542.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas ASHAPURMIN.BO's P/E ratio is 13.83. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to ASHAPURMIN.BO's ROE of +0.31%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to ASHAPURMIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check ASHAPURMIN.BO's competition here
EMAMIPAP.NS vs ORISSAMINE.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, ORISSAMINE.NS has a market cap of 25.2B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while ORISSAMINE.NS trades at ₹4,209.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas ORISSAMINE.NS's P/E ratio is -94.16. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to ORISSAMINE.NS's ROE of +0.64%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to ORISSAMINE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check ORISSAMINE.NS's competition here
EMAMIPAP.NS vs ORISSAMINE.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, ORISSAMINE.BO has a market cap of 25.1B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while ORISSAMINE.BO trades at ₹4,187.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas ORISSAMINE.BO's P/E ratio is -65.09. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to ORISSAMINE.BO's ROE of +0.64%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to ORISSAMINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check ORISSAMINE.BO's competition here
EMAMIPAP.NS vs JGCHEM.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, JGCHEM.NS has a market cap of 13.9B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while JGCHEM.NS trades at ₹357.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas JGCHEM.NS's P/E ratio is 22.00. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to JGCHEM.NS's ROE of +0.13%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to JGCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check JGCHEM.NS's competition here
EMAMIPAP.NS vs 20MICRONS.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, 20MICRONS.NS has a market cap of 6.2B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while 20MICRONS.NS trades at ₹177.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas 20MICRONS.NS's P/E ratio is 9.57. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to 20MICRONS.NS's ROE of +0.15%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to 20MICRONS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check 20MICRONS.NS's competition here
EMAMIPAP.NS vs 20MICRONS.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, 20MICRONS.BO has a market cap of 6.2B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while 20MICRONS.BO trades at ₹176.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas 20MICRONS.BO's P/E ratio is 9.56. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to 20MICRONS.BO's ROE of +0.15%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to 20MICRONS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check 20MICRONS.BO's competition here
EMAMIPAP.NS vs SCFL.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, SCFL.BO has a market cap of 5.9B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while SCFL.BO trades at ₹26.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas SCFL.BO's P/E ratio is N/A. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to SCFL.BO's ROE of -0.05%. Regarding short-term risk, EMAMIPAP.NS is less volatile compared to SCFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check SCFL.BO's competition here
EMAMIPAP.NS vs RAJMET.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, RAJMET.NS has a market cap of 1.1B. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while RAJMET.NS trades at ₹3.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas RAJMET.NS's P/E ratio is -48.62. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to RAJMET.NS's ROE of -0.02%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to RAJMET.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check RAJMET.NS's competition here
EMAMIPAP.NS vs SICAGEN.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, SICAGEN.NS has a market cap of 973.5M. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while SICAGEN.NS trades at ₹24.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas SICAGEN.NS's P/E ratio is -164.00. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to SICAGEN.NS's ROE of +0.04%. Regarding short-term risk, EMAMIPAP.NS is less volatile compared to SICAGEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check SICAGEN.NS's competition here
EMAMIPAP.NS vs PATSPINLTD.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, PATSPINLTD.NS has a market cap of 436M. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while PATSPINLTD.NS trades at ₹14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas PATSPINLTD.NS's P/E ratio is -3.18. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to PATSPINLTD.NS's ROE of +0.33%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to PATSPINLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check PATSPINLTD.NS's competition here
EMAMIPAP.NS vs IMPEXFERRO.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, IMPEXFERRO.BO has a market cap of 149.5M. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while IMPEXFERRO.BO trades at ₹1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas IMPEXFERRO.BO's P/E ratio is -2.05. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to IMPEXFERRO.BO's ROE of +0.02%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to IMPEXFERRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check IMPEXFERRO.BO's competition here
EMAMIPAP.NS vs IMPEXFERRO.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, IMPEXFERRO.NS has a market cap of 148.6M. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while IMPEXFERRO.NS trades at ₹1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas IMPEXFERRO.NS's P/E ratio is -2.04. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to IMPEXFERRO.NS's ROE of +0.02%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to IMPEXFERRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check IMPEXFERRO.NS's competition here
EMAMIPAP.NS vs ARENTERP.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, ARENTERP.BO has a market cap of 131.8M. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while ARENTERP.BO trades at ₹42.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas ARENTERP.BO's P/E ratio is -66.25. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to ARENTERP.BO's ROE of -0.00%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to ARENTERP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check ARENTERP.BO's competition here
EMAMIPAP.NS vs ARENTERP.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, ARENTERP.NS has a market cap of 125.4M. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while ARENTERP.NS trades at ₹42.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas ARENTERP.NS's P/E ratio is -63.02. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to ARENTERP.NS's ROE of -0.00%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to ARENTERP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check ARENTERP.NS's competition here
EMAMIPAP.NS vs PRECISION.BO Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, PRECISION.BO has a market cap of 48.3M. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while PRECISION.BO trades at ₹54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas PRECISION.BO's P/E ratio is -495.41. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to PRECISION.BO's ROE of +0.00%. Regarding short-term risk, EMAMIPAP.NS is less volatile compared to PRECISION.BO. This indicates potentially lower risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check PRECISION.BO's competition here
EMAMIPAP.NS vs METKORE.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, METKORE.NS has a market cap of 47.2M. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while METKORE.NS trades at ₹0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas METKORE.NS's P/E ratio is -0.40. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to METKORE.NS's ROE of -1.25%. Regarding short-term risk, EMAMIPAP.NS is less volatile compared to METKORE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check METKORE.NS's competition here
EMAMIPAP.NS vs ORIENTREF.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, ORIENTREF.NS has a market cap of 0. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while ORIENTREF.NS trades at ₹324.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas ORIENTREF.NS's P/E ratio is 53.11. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to ORIENTREF.NS's ROE of +0.22%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to ORIENTREF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check ORIENTREF.NS's competition here
EMAMIPAP.NS vs SEZAL.NS Comparison February 2026
EMAMIPAP.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMAMIPAP.NS stands at 5.2B. In comparison, SEZAL.NS has a market cap of 0. Regarding current trading prices, EMAMIPAP.NS is priced at ₹86.70, while SEZAL.NS trades at ₹5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMAMIPAP.NS currently has a P/E ratio of 18.05, whereas SEZAL.NS's P/E ratio is -0.00. In terms of profitability, EMAMIPAP.NS's ROE is +0.05%, compared to SEZAL.NS's ROE of +0.15%. Regarding short-term risk, EMAMIPAP.NS is more volatile compared to SEZAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for EMAMIPAP.NS.Check SEZAL.NS's competition here